Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points but might predict a much higher risk of reintervention.

Impacto del FFR post stent ¿dato útil o solo una curiosidad?

FFR has shown a huge impact on the decision-making process when it comes to revascularizing (or not) a lesion. Its impact after angioplasty has not been fully studied, particularly in the long term. We know the thresholds before angioplasty, but should there be target values after that procedure? If FFR does not improve as much as we expected after stenting, should it be optimized, somehow?

This large-scale study included all patients who underwent FFR-guided angioplasty.

FFR was measured immediately after angioplasty and then once the operator considered the outcome as acceptable and final. These results were only observational, since no action was taken based on them.

A suboptimal result was defined as final FFR <0.90. The final endpoint was a composite of cardiac death, infarction, and any revascularization after a 2-year follow-up.

With 1000 patients included and 1165 vessels analyzed, FFR after angioplasty was <0.9 in 440 vessels (37.8%). Almost 400 patients left the cath lab with at least one vessel whose FFR was suboptimal. This accounts for over a third of the procedures; its frequency is surprising. We should remember that no action was taken based on these results.


Read also: FREEDOM with FFR: Different Outcomes?


The analysis per patient did not show a significant association between FFR results after angioplasty and combined events after 2 years of follow-up (hazard ratio [HR]: 1.08, 95% confidence interval [CI]: 0.73 to 1.60; p = 0.707). Upon consideration of each event separately, no association was found either.

The analysis per vessel offered different results. FFR <0.9 after angioplasty was associated with almost twice as many target-vessel revascularizations (HR: 1.91; 95% CI: 1.06 to 3.44; p = 0.030) and a higher risk for thrombosis.

Conclusion

Suboptimal FFR after angioplasty had no significant impact on hard cardiovascular events, but it was associated with almost twice as many target-vessel revascularizations.

CIRCINTERVENTIONS-120-009681FREE

Original Title: Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes. The FFR-SEARCH Study.

Reference: Roberto Diletti et al. Circ Cardiovasc Interv. 2021;14:e009681. DOI: 10.1161/CIRCINTERVENTIONS.120.009681.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...